Listing 3 - Actual negotiations

Indication:

Chronic Immune Thrombocytopenia

Indication:

Multiple Myeloma (including relapsed)

Indication:

Pulmonary Arterial Hypertension

Indication:

Atopic dermatitis

Indication:

Atherothrombotic Events in Coronary Artery Disease

Indication:

Acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) or newly diagnosed therapy-related acute myeloid leukaemia (t-AML) , in adults

Indication:

Ischemic events in statin-treated patients

Indication:

Myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS with the following French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, and chronic myelomonocytic leukemia [CMML]) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System (IPSS) groups, in adult patients

Indication:

Parkinson's disease

Indication:

Diabetes Mellitus, Type 1 & 2